Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
Clinical trial NCT02511639 · COMPLETED
Trial details
- NCT number
- NCT02511639
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-30
- Primary completion
- 2020-02-28
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.